Abstract:Compared to the conventional anti-cancer drugs, the nano-drug delivery systems (NDDS) shows a comparatively ideal therapeutic efficacy ascribing their high tumor-target capacity and efficient drug release ability. In this study, a novel macromolecular prodrug conjugate was designed and developed that is passively triggered by the acidic environment of the tumor cells and can release doxorubicin (Dox). The susceptibility of the system to the acidic environment is due to the acid volatile Schiff base covalent bond between grafted carboxymethyl chitosan (CMCs) and Dox. The chemical structure of the finalized system was characterized by 1H-NMR spectroscopy. Because of the hydrophobicity of the Dox and the hydrophilicity of the CMCs, the amphipathic polymeric drug conjugates can self-assemble into the nanoparticles in aqueous solution. The morphology and size of the nanoparticles were observed with TEM (transmission electron microscopy) and DLS (dynamic light scattering). The in vitro drug release studies demonstrated that the drug release rate of the prodrug were visibly higher in acidic conditions (pH 5.0) compared to higher pHs like 6.5 and 7.4. DLS results showed that the mean size of the prodrug nanoparticles increased as the pH of the solution decreased from 7.4 to 6.5 and 5.0. Furthermore, the cell counting kit-8 (CCK-8) assays showed that the polymeric drug nanoparticles had a cytotoxic effect on SKOV3 ovarian cancer cells while the segments of the DDS revealed comparatively lower cytotoxic effect. Moreover, confocal laser scanning microscopy (CLSM) showed that the prodrug could efficiently deliver and release Dox in the nuclei of the cancer cells while this was not observed for the Dox pure drug. These results proved that the carboxymethyl chitosan-CBA-Doxorubicin NPs have superior stabilities, low toxicities, proper sizes, and enhanced curable efficiency for in vitro controlled release. Thus, this pH-sensitive prodrug could be a potential treatment for cancer therapy in the near future.

In Vitro Binding and Release Mechanisms of Doxorubicin from Nanoclays

Acid-responsive intracellular doxorubicin release from click chemistry functionalized mesoporous silica nanoparticles

Intercalated 2D nanoclay for emerging drug delivery in cancer therapy

A Preloaded Amorphous Calcium Carbonate/Doxorubicin@Silica Nanoreactor for Ph‐responsive Delivery of an Anticancer Drug

Doxorubicin Loading Capacity of Shell Cross-Linked Micelles with Ph-Responsive Core As Anticancer Drug Delivery Nanocarriers

Ph and Thermal Dual-Responsive Nanoparticles for Controlled Drug Delivery with High Loading Content

Preparation and Characterization of Modified Lipid Nanoparticles for Doxorubicin Controlled Release.

Control of Nanodiamond-Doxorubicin Drug Loading and Elution Through Optimized Compositions and Release Environments

In Situ Biodegradable Crosslinking of Cationic Oligomer Coating on Mesoporous Silica Nanoparticles for Drug Delivery

Effect of Surface Functionalization and Pore Structure Type on the Release Performance of Mesoporous Silica Nanoparticles

Synthesis and in Vitro Characterization of Carboxymethyl Chitosan-CBA-Doxorubicin Conjugate Nanoparticles As Ph-Sensitive Drug Delivery Systems

Preparation, Drug Release and Cellular Uptake of Doxorubicin-Loaded Dextran-B-poly(ɛ-caprolactone) Nanoparticles

Doxorubicin hydrochloride-oleic acid conjugate loaded nanostructured lipid carriers for tumor specific drug release.

Self-Assembled Hyaluronic Acid Nanoparticles for Ph-Sensitive Release of Doxorubicin: Synthesis and in Vitro Characterization.

Core–shell SrTiO3:Yb3+,Er3+@mSiO2 nanoparticles for controlled and monitored doxorubicin delivery

Facile Preparation of Core Cross-Linked Nanomicelles Based on Graft Copolymers with Ph Responsivity and Reduction Sensitivity for Doxorubicin Delivery.

A Facile Synthesis of Acid-Activatable Nanoparticles for Efficient Intracellular Doxorubicin Release

Preparation and Characteristics of Doxorubicin-Loaded Carboxylic Acid-Functionalized Mesoporous Silica Nanoparticles

Synthesis and Characterization of Doxorubicin Loaded Ph-Sensitive Magnetic Core-Shell Nanocomposites for Targeted Drug Delivery Applications

Polyvinyl pyrrolidone/starch/hydroxyapatite nanocomposite: A promising approach for controlled release of doxorubicin in cancer therapy

Facile Synthesis by a Covalent Binding Reaction for Ph-Responsive Drug Release of Carboxylated Chitosan Coated Hollow Mesoporous Silica Nanoparticles